Skip to main content
Equibles

US BANCORP \DE\

Bank

Position in SCLX — Scilex Holding Co

CIK 36104 MINNEAPOLIS, MN
Back to SCLX Full portfolio

Position in SCLX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$85
+$32 QoQ
Shares Held
11
-15.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 72 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SCLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

US BANCORP \DE\ holds $3,650,078,543 across 17 Drug Manufacturers - General names. SCLX ranks #17 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 1,354,723 $1,624,895,541
2 JNJ
Johnson & Johnson
 2,500,270 $634,993,570
3 ABBV
AbbVie Inc.
 2,295,401 $577,614,705
4 AMGN
Amgen Inc
 664,266 $240,544,002
5 MRK
Merck & Co., Inc.
 1,561,329 $200,630,776
6 GILD
Gilead Sciences, Inc.
 852,290 $107,678,317
7 PFE
Pfizer Inc
 3,685,691 $88,751,436
8 BMY
Bristol Myers Squibb Co
 1,291,483 $74,415,248

All Filings in SCLX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $85 11
2026-03-31 $53 8
2025-12-31 $85 7
2025-09-30 $1,121 57
2025-06-30 $41 7
2025-03-31 $881 3,539
2024-12-31 $306 719
2024-09-30 $4,185 4,526
2024-06-30 $8,734 4,526
2024-03-31 $7,196 4,526
2023-12-31 $9,232 4,526
2023-09-30 $6,335 4,526
2023-06-30 $25,209 4,526
2023-03-31 $36,998 4,512